39 results found
ENDRA Life Sciences Inc. (NASDAQ: NDRA) is gaining increasing investor attention as the company advances its TAEUS® Liver imaging platform while…
A number of actively traded small-cap and growth stocks are drawing increased investor attention as momentum continues building across sectors…
A new wave of momentum is building among several actively traded stocks under $5 as investors continue searching for exposure to high-growth…
A new wave of corporate developments across biotech, clean energy, travel infrastructure, and medical diagnostics is putting several small- and…
As the global healthcare system rapidly scales to treat metabolic dysfunction–associated steatotic liver disease (MASLD) and expand GLP-1 therapies, ENDRA Life Sciences (NASDAQ:…
While investors chase the GLP-1 drug boom, a critical bottleneck is emerging that could reshape the entire market—liver imaging simply…
A renewed spotlight is forming around a group of small-cap healthcare companies as U.S. policy shifts toward accelerating research into…
As the global race to treat metabolic dysfunction–associated steatotic liver disease (MASLD) and expand GLP-1 therapies accelerates, a critical challenge is emerging across the…
As metabolic dysfunction–associated steatotic liver disease (MASLD) and MASH move toward large-scale clinical adoption, ENDRA Life Sciences (NASDAQ: NDRA) is emerging as a key player in…
A diverse group of small- and mid-cap companies across defense technology, digital assets, biotech, energy, and education are drawing increased investor focus…
